Intestinal inflammation and compromised barrier function in idiopathic parkinsonism: scenario captured by systematic review

Chianna Umamahesan, Aisha D. Augustin, B. Hayee, M. Ibrahim, David Taylor, C. Weller, A. Charlett, R. Dobbs, S. Dobbs
{"title":"Intestinal inflammation and compromised barrier function in idiopathic parkinsonism: scenario captured by systematic review","authors":"Chianna Umamahesan, Aisha D. Augustin, B. Hayee, M. Ibrahim, David Taylor, C. Weller, A. Charlett, R. Dobbs, S. Dobbs","doi":"10.20517/2347-8659.2020.57","DOIUrl":null,"url":null,"abstract":"Aim: To address how common are intestinal inflammation and compromised barrier function in idiopathic parkinsonism (IP), any potential treatment benefits, outcome of not treating, and whether screening is worthwhile. This may provide the missing link between systemic/brain inflammation in IP and implicated gastrointestinal microbiota/specific pathogens. Methods: Search strategy was based on PRISMA guidelines. Fifteen of the 1395 articles (1995-2020) identified met the inclusion criteria. Seven gave results on more than one intestinal modality: inflammation, permeability, integrity, and bacterial translocation. Results: The inter-relationship of IP with intestinal inflammation and bacterial translocation is firmly established, lacking only random sample surveys to meet Level-1 Oxford Centre for Evidence-Based Medicine evidence. Evidence for reduced integrity is limited to 2 small studies of tight-junction proteins in colonic biopsies. No overall conclusion can be drawn from studies of faecal and circulating markers of integrity: evidence based on an assay that recognizes wider zonulin family, not the specific peptide exclusively, was censored. Evidence for increased permeability is Page 2 Umamahesan et al. Neuroimmunol Neuroinflammation 2021;8:[Online First] I http://dx.doi.org/10.20517/2347-8659.2020.57 insubstantial: further work is needed in IP with and without small-intestinal-bacterial-overgrowth and including a non-fermentable sugar absorption test. Concentrations of markers of intestinal inflammation (faecal calprotectin) and bacterial translocation (circulating lipopolysaccharide-binding protein) appear not to change with time-sincediagnosis or IP severity. This is compatible with a pre-presentation insult. There are no longitudinal studies on inflammation or translocation to guide design of interventional studies. Neither are cut-points discriminant for IPfacets, or gradients prognostic for its evolution, defined. Conclusion: Intestinal inflammation and barrier function is a strategic junctional point in the hypothesis for the aetipathogenesis of IP.","PeriodicalId":19129,"journal":{"name":"Neuroimmunology and Neuroinflammation","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroimmunology and Neuroinflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20517/2347-8659.2020.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Aim: To address how common are intestinal inflammation and compromised barrier function in idiopathic parkinsonism (IP), any potential treatment benefits, outcome of not treating, and whether screening is worthwhile. This may provide the missing link between systemic/brain inflammation in IP and implicated gastrointestinal microbiota/specific pathogens. Methods: Search strategy was based on PRISMA guidelines. Fifteen of the 1395 articles (1995-2020) identified met the inclusion criteria. Seven gave results on more than one intestinal modality: inflammation, permeability, integrity, and bacterial translocation. Results: The inter-relationship of IP with intestinal inflammation and bacterial translocation is firmly established, lacking only random sample surveys to meet Level-1 Oxford Centre for Evidence-Based Medicine evidence. Evidence for reduced integrity is limited to 2 small studies of tight-junction proteins in colonic biopsies. No overall conclusion can be drawn from studies of faecal and circulating markers of integrity: evidence based on an assay that recognizes wider zonulin family, not the specific peptide exclusively, was censored. Evidence for increased permeability is Page 2 Umamahesan et al. Neuroimmunol Neuroinflammation 2021;8:[Online First] I http://dx.doi.org/10.20517/2347-8659.2020.57 insubstantial: further work is needed in IP with and without small-intestinal-bacterial-overgrowth and including a non-fermentable sugar absorption test. Concentrations of markers of intestinal inflammation (faecal calprotectin) and bacterial translocation (circulating lipopolysaccharide-binding protein) appear not to change with time-sincediagnosis or IP severity. This is compatible with a pre-presentation insult. There are no longitudinal studies on inflammation or translocation to guide design of interventional studies. Neither are cut-points discriminant for IPfacets, or gradients prognostic for its evolution, defined. Conclusion: Intestinal inflammation and barrier function is a strategic junctional point in the hypothesis for the aetipathogenesis of IP.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
特发性帕金森综合征的肠道炎症和屏障功能受损:系统综述
目的:探讨肠道炎症和屏障功能受损在特发性帕金森病(IP)中有多常见,任何潜在的治疗益处,不治疗的结果,以及筛查是否值得。这可能提供了IP中全身性/脑部炎症与相关胃肠道微生物群/特定病原体之间缺失的联系。方法:检索策略基于PRISMA指南。确定的1395篇文章(1995-2020)中有15篇符合纳入标准。其中7个给出了不止一种肠道形态的结果:炎症、通透性、完整性和细菌易位。结果:IP与肠道炎症和细菌易位之间的相互关系是明确的,仅缺乏随机抽样调查,以满足牛津循证医学中心的一级证据。完整性降低的证据仅限于结肠活检中紧密连接蛋白的2个小型研究。从粪便和循环完整性标记物的研究中无法得出总体结论:基于识别更广泛的zonulin家族而不是特定肽的检测的证据被删除。渗透率增加的证据见第2页Umamahesan等人。Neuroimmunol Neuroinflammation 2021;8:[Online First] I http://dx.doi.org/10.20517/2347-8659.2020.57不实质性:有或没有小肠-细菌-过度生长的IP需要进一步的工作,包括不可发酵糖吸收测试。肠道炎症标志物(粪便钙保护蛋白)和细菌易位(循环脂多糖结合蛋白)的浓度似乎不随诊断时间或IP严重程度而改变。这与演讲前的侮辱是一致的。没有关于炎症或易位的纵向研究来指导介入性研究的设计。对于ipfacet来说,切点并不是判别性的,对于ipfacet的演化,也没有定义梯度预测。结论:肠道炎症与屏障功能是IP发病机制假说的重要结合点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
348
期刊最新文献
Acknowledgment to Reviewers Neurological connections and endogenous biochemistry - potentially useful in electronic-nose diagnostics for coronavirus diseases Use of intravenous immunoglobulin to successfully treat COVID-19 associated encephalitis Viruses and neuroinflammation in multiple sclerosis Pathways linking Alzheimer’s disease risk genes expressed highly in microglia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1